Sequential administration of paclitaxel and doxorubicin followed by CMF in women with advanced breast cancer

被引：0
|
作者：
Papadimitriou, C
Dimopoulos, M
Lazaris, D
Ampela, C
Louvrou-Fertaki, A
Athanassiades, P
Stamatelopoulos, S
Keramopoulos, A
机构：
[1] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Alexandra Hosp, Dept Obstet & Gynecol, GR-11527 Athens, Greece
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(98)80050-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
49
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [1] Sequential administration of doxorubicin and paclitaxel followed by cyclophosphamide, methotrexate and 5-fluorouracil combination (CMF) in women with metastatic breast cancer
    Papadimitriou, CA
    Dimopoulos, MA
    Ampela, C
    Louvrou-Fertaki, A
    Anagnostopoulos, A
    Athanassiades, P
    Stamatelopoulos, S
    Keramopoulos, A
    [J]. ONCOLOGY, 1998, 55 (06) : 533 - 537
  • [2] The sequential administration of combined doxorubicin and paclitaxel in the treatment of advanced breast cancer
    Frassineti, GL
    Zoli, W
    Tienghi, A
    Ravaioli, A
    Milandri, C
    Gentile, A
    Salzano, E
    Amadori, D
    [J]. SEMINARS IN ONCOLOGY, 1996, 23 (05) : 22 - 28
  • [3] Doxorubicin (Adriamycin, A) plus paclitaxel (T) followed by weekly paclitaxel (wT) as primary chemotherapy for women with locally advanced breast cancer (LABC).
    Zambetti, M
    Mariani, G
    Citterio, G
    Valagussa, P
    Greco, M
    Tomasic, G
    Lozza, L
    Piotti, P
    Gianni, L
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S110 - S110
  • [4] Doxorubicin plus paclitaxel in advanced breast cancer
    Dombernowsky, P
    Boesgaard, M
    Andersen, E
    Jensen, PV
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (05) : 15 - 18
  • [5] A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer
    Amadori, D
    Frassineti, GL
    Zoli, W
    Milandri, C
    Tienghi, A
    Ravaioli, A
    Gentile, A
    Salzano, E
    [J]. SEMINARS IN ONCOLOGY, 1996, 23 (05) : 16 - 22
  • [6] DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN, PACLITAXEL AND CMF VERSUS EPIRUBICIN, CMF AND WEEKLY DOCETAXEL OR PACLITAXEL FOLLOWED BY TRASTUZUMAB FOR ONE YEAR IN PATIENTS WITH EARLY BREAST CANCER
    Fountzilas, G.
    Gogas, H.
    Pavlidis, N.
    Eleftheraki, A.
    Skarlos, D.
    Koutras, A.
    Timotheadou, E.
    Papandreou, C.
    Pectasides, D.
    Dimopoulos, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 95 - 95
  • [7] Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy for Women With High-Risk Breast Cancer
    Loesch, David
    Greco, F. Anthony
    Senzer, Neil N.
    Burris, Howard A.
    Hainsworth, John D.
    Jones, Stephen
    Vukelja, Svetislava J.
    Sandbach, John
    Holmes, Frankie
    Sedlacek, Scot
    Pippen, John
    Lindquist, Deborah
    McIntyre, Kristi
    Blum, Joanne L.
    Modiano, Manuel R.
    Boehm, Kristi A.
    Zhan, Feng
    Asmar, Lina
    Robert, Nicholas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18) : 2958 - 2965
  • [8] Prolonged primary chemotherapy (PC) with doxorubicin (A) plus paclitaxel (T) followed by weekly paclitaxel (AT&T) in women with inoperable locally advanced breast cancer (LABC).
    Zambetti, M
    Mariani, G
    Buglione, M
    Greco, M
    Bergonzi, S
    Tomasic, G
    Lozza, L
    Piotti, P
    Valagussa, P
    Gianni, L
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 23 - 23
  • [9] Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic
    Gehl, J
    Boesgaard, M
    Paaske, T
    Jensen, BV
    Dombernowsky, P
    [J]. ANNALS OF ONCOLOGY, 1996, 7 (07) : 687 - 693
  • [10] Sequential administration of epirubicin and paclitaxel for advanced breast cancer. A phase I randomised trial
    Focan, C
    Graas, MP
    Beauduin, M
    Canon, JL
    Salmon, JP
    Jerusalem, G
    Focan-Henrard, D
    Lobelle, JP
    Schallier, D
    [J]. ANTICANCER RESEARCH, 2005, 25 (2B) : 1211 - 1217
12345